Quantcast

Latest Menorrhagia Stories

2010-12-01 07:00:00

MORRISTOWN, N.J., Dec. 1, 2010 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), announced today that ella® (ulipristal acetate) 30 mg, a novel oral emergency contraceptive, is now available for patients by prescription in the U.S. ella® was approved by the U.S.

2010-11-22 07:00:00

SAN DIEGO, Nov. 22, 2010 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc.

2010-11-09 14:28:00

BEDFORD, Mass., Nov. 9, 2010 /PRNewswire/ -- Booth #410 -- Hologic, Inc.

2010-10-06 08:00:00

PARSIPPANY, N.J., Oct. 6 /PRNewswire/ -- Ferring Pharmaceuticals Inc. today announced publication of one of its pivotal Phase 3 trials of LYSTEDA(TM) (tranexamic acid) tablets for cyclic heavy menstrual bleeding (HMB) in the October issue of the peer-reviewed journal, Obstetrics & Gynecology.

2010-09-29 13:53:30

Intrauterine devices, originally developed as contraceptives, can also be used to treat and cure cancer of the endometrium according to new research published online in the cancer journal, Annals of Oncology [1] today (Wednesday 29 September).

2010-09-14 08:00:00

PARSIPPANY, N.J., Sept. 14 /PRNewswire/ -- Nearly ninety percent of women who experience heavy periods(1) believe their life during their period would greatly improve if they could reduce their menstrual flow, according to a new Harris Interactive® survey commissioned by Ferring Pharmaceuticals.

2010-08-11 14:03:59

Primary dysmenorrhea (PDM), or menstrual cramps, is the most common gynecological disorder in women of childbearing age.

2010-07-12 13:00:00

BEDFORD, Mass., July 12 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced that Glenn Muir, Chief Financial Officer, will present at the Canaccord Genuity 30th Annual Growth Conference 2010 on Wednesday, August 11, 2010 at 1:00 p.m.

2010-06-21 08:00:00

PARSIPPANY, N.J., June 21 /PRNewswire/ -- Ferring Pharmaceuticals Inc. announced today the U.S.

2010-06-16 05:31:00

ABBOTT PARK, Ill. and SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) and Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain.


Word of the Day
saggar
  • A ceramic container used inside a fuel-fired kiln to protect pots from the flame.
The word 'saggar' may come from 'safeguard'.
Related